News & Perspective

May 17, 2019

May 17, 2019

ASP Scan (Weekly) for May 17, 2019

Northern Ireland AMR plan
Rapid susceptibility tests
Unnecessary abx for respiratory infections
Antibiotics in school beef
UK veterinary stewardship policy
Improper prescribing in seniors
Resistant TB testing in China
Antibiotic production partnership
MCR-1 in chickens, camels
New CARB-X funding
Grant for TB research

Nov 11, 2016

Nov 11, 2016

Flu Scan for Nov 11, 2016

H7N9 in China
Influenza imprinting
More avian flu in Europe

Jan 08, 2016

Jan 08, 2016
Young calf

New MCR-1 reports warn of untreatable infection threat

The new, worrisome MCR-1 resistance gene has been detected in 6 more nations.

Aug 21, 2015

Aug 21, 2015

News Scan for Aug 21, 2015

NY Legionella source
H5N6 in Vietnam
C diff virulence
Jamboree-linked meningococcal disease outbreak
Airborne spread of swine viruses

Feb 17, 2011

Feb 17, 2011

WHO sticks with current strains for next flu vaccine

(CIDRAP News) – Signaling that the current flu strains are likely to persist over the next several months, the World Health Organization (WHO) today recommended sticking with the current trio of vaccine strains for the Northern Hemisphere's next influenza season.

The WHO's vaccine strain advisory committee met on Feb 15 and 16 and released its recommendation on the WHO's Web site. The group recommends the following for next season's vaccine:

May 19, 2008

May 19, 2008

EU approves its first prepandemic H5N1 vaccine

(CIDRAP News) – An H5N1 influenza vaccine made by the British pharmaceutical company GlaxoSmithKline (GSK) has become the first prepandemic vaccine to be licensed by the European Union (EU), the company announced today.

Mar 27, 2008

Mar 27, 2008

Swiss find H5N1 in wild duck; India has new outbreak

(CIDRAP News) – Animal health officials in Switzerland today said samples from an asymptomatic duck were positive for H5N1 avian influenza, as officials in India announced a poultry outbreak in another district in West Bengal state.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Aug 16, 2007

Aug 16, 2007

Glaxo sells more H5N1 vaccine to US, launches trial

(CIDRAP News) – The British pharmaceutical company GlaxoSmithKline (GSK) recently announced another major order of prepandemic H5N1 influenza vaccine from the US Department of Health and Human Services (HHS), along with plans to launch a North American clinical trial of the vaccine.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»